Thanks, Ivonne. I started reading this earlier the got distracted so this jogged my memory. I guess the problem is politics - which happens in business anyway - but when elected politicians are involved they want someone to blame! AstraZeneca's inexperience with vaccine development and manufacturing cawnt have helped - it does seem some data has been a little messy and perhaps they did over promise on delivery? Not a major problem in normal times but when politicians are out of their comfort zone things are different.It might not be bad long-term: if things settle down and the vaccine helps then they may get kudos for their approach - and they'll certainly have learnt a lot about the vaccine market!Interesting - I thought from something else I'd read that Vaccitech Ltd owned the patents and were licensing it to AZ, Serum Institute of India ... but I may have misunderstood that; AZ may have patents that turn the research into a production vaccine?
Michael Ixer ● 2049d